PHILADELPHIA, PA / ACCESSWIRE / August 26, 2021 / Kaskela Law LLC is investigating Rafael Holdings, Inc. ("Rafael Holdings") (NYSE:RFL) on behalf of the company's stockholders.
On June 21, 2021, Rafael Holdings announced that it had entered into an agreement to acquire Rafael Pharmaceuticals, Inc. ("Pharmaceuticals") in an all-stock transaction. According to the announcement, following the proposed transaction Pharmaceuticals' stockholders are expected to own approximately 48% of the company.
The investigation seeks to determine whether Rafael Holdings' board of directors breached their fiduciary duties in connection with the proposed transaction to acquire Pharmaceuticals, and whether RFL stockholders have been harmed by such actions.
Rafael Holdings stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 - 1585, or by email at [email protected], to discuss this investigation and their legal rights and options. Stockholders may also visit https://kaskelalaw.com/case/rafael-holdings-inc/ for additional information.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 258 - 1585
(888) 715 - 1740
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
SOURCE: Kaskela Law LLC